Dr. Galkin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
41 Burlington Mall Rd
Burlington, MA 01805
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 2020 - 2023
University of California Davis HealthChief Residency, Internal Medicine, 2019 - 2020- University of California Davis HealthResidency, Internal Medicine, 2017 - 2019
Lewis Katz School of Medicine at Temple UniversityClass of 2016, MD
Certifications & Licensure
MA State Medical License 2020 - 2025
CA State Medical License 2017 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 2 citationsA phase II trial of decitabine, bortezomib and pegylated liposomal doxorubicin for the treatment of relapsed or refractory AML.Brian A Jonas, Laura A Potter, Maria Galkin, Joseph M Tuscano
Leukemia Research Reports. 2023-01-01 - 17 citationsEnasidenib in the treatment of relapsed/refractory acute myeloid leukemia: an evidence-based review of its place in therapyMaria Galkin, Brian A. Jonas
Core Evidence. 2019-04-26 - 3 citationsDiagnostic Dilemma: Carcinoid SyndromeNeil Beri, Amir Farid, Maria Galkin, William R. Lewis, Ezra A. Amsterdam
The American Journal of Medicine. 2018-06-12
Other Languages
- Russian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
